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Pathogen-induced cancers account for 15% of human tumors and are a growing concern for
endangered wildlife. Fibropapillomatosis is an expanding virally and environmentally co-
induced sea turtle tumor epizootic. Chelonid herpesvirus 5 (ChHV5) is implicated as a
causative virus, but its transmission method and specific role in oncogenesis and progression
is unclear. We applied environmental (e)DNA-based viral monitoring to assess viral shedding
as a direct means of transmission, and the relationship between tumor burden, surgical
resection and ChHV5 shedding. To elucidate the abundance and transcriptional status of
ChHV5 across early, established, regrowth and internal tumors we conducted genomics and
transcriptomics. We determined that ChHV5 is shed into the water column, representing a
likely transmission route, and revealed novel temporal shedding dynamics and tumor burden
correlations. ChHV5 was more abundant in the water column than in marine leeches. We
also revealed that ChHV5 is latent in fibropapillomatosis, including early stage, regrowth and
internal tumors; higher viral transcription is not indicative of poor patient outcome, and high
ChHV5 loads predominantly arise from latent virus. These results expand our knowledge of
the cellular and shedding dynamics of ChHV5 and can provide insights into temporal
transmission dynamics and viral oncogenesis not readily investigable in tumors of terrestrial
species.
https://doi.org/10.1038/s42003-021-02085-2 OPEN
1 The Whitney Laboratory for Marine Bioscience and Sea Turtle Hospital, University of Florida, St. Augustine, FL, USA. 2Department of Biology, University of
Florida, Gainesville, FL, USA. 3 Department of Biological Sciences, School of Natural Sciences, Faculty of Science and Engineering, University of Limerick,
Limerick, Ireland. 4Molecular Ecology and Fisheries Genetics Laboratory, School of Biological Sciences, Bangor University, Bangor, Gwynedd, UK. 5These
authors contributed equally: Jessica A. Farrell, Kelsey Yetsko. ✉email: duffy@whitney.ufl.edu









Sea turtle fibropapillomatosis (FP) is an epizootic (animalepidemic) tumor disease, affecting endangered sea turtlesworldwide1–5. The disease is characterized by the formation
of cutaneous and internal fibro-epithelial tumors, which can lead
to debilitation and death. Fibropapillomatosis of sea turtles con-
tinues to spread geographically, and is now present in every major
ocean basin in which green sea turtles (Chelonia mydas) are
endemic (www.cabi.org/isc/datasheet/82638)3,6–16. Rates of FP
are also increasing in many long-term affected locations, with
incidence of the disease being the highest in near-shore
habitats3,9,17–21. The FP-afflicted turtles studied here were
found stranded in northeastern Florida. Fibropapillomatosis only
began affecting C. mydas in northern Florida in the last decade,
despite being present in areas of southern Florida since at least
the early 1900s5,12,19,22–24. Concurrent with geographic expan-
sion of the disease, incidence of FP in stranded C. mydas across
the state of Florida has risen from 13.3% in 2005 to 42% in
20165,9,17,19.
Of all sea turtle species and life-stages, juvenile green sea turtles
are most severely afflicted by FP. Long-lived reptiles have nor-
mally robust anti-cancer defenses, and with the exception of FP,
reports of neoplasia in sea turtles are rare25–29. However, near-
shore environmental exposures likely impair tumor suppressor
mechanisms in sea turtles, thereby enabling virally-induced
tumorigenesis3,30. While some environmental co-factors, such
as eutrophication have been studied, their role in the pathogenesis
of FP remains experimentally unconfirmed. It is possible that
environmental exposures induce immunosuppression in sea tur-
tles, thereby enabling viral loads to increase to the point of
crossing an oncogenic threshold, similar to a number of human
virally-induced cancers3,5,31–33. However, the pathogenesis of FP
remains elusive. A chelonian-specific alphaherpesvirus (chelonid
herpesvirus 5, ChHV5) has been implicated as a cause. However,
Koch’s postulates to confirm its causative role have yet to be
fulfilled, because ChHV5 is extremely difficult to isolate and
propagate in the laboratory3,5,34–37. Similarly, despite advances in
FP tumor research1,3,5,30,31,38–46, many open questions remain
regarding the role of ChHV5 in driving FP tumorigenesis,
including whether it is a cause of the disease or an opportunistic
pathogen, exploiting immunocompromised tumor-afflicted
turtles3,5,31. Interestingly, levels of ChHV5 (ChHV5 gB and
UL30 gene DNA detected by qPCR, and ChHV5 glycoprotein H
peptides detected by ELISA) in clinically healthy turtles are closer
to that of FP tumors, than in non-tumored tissue of FP-afflicted
turtles34,47. It is also unclear whether ChHV5 is lytic or latent in
FP tumors and the occurrence of viral shedding and transmission
is not well understood3,5,48–51.
In many locations, such as Florida, live sea turtles with FP that
are found stranded are admitted to rehabilitation facilities for
treatment, which often includes tumor resection surgery. Sea
turtles under treatment for FP provide a valuable opportunity to
study this disease in a manner that is infeasible or impractical in
free-ranging animals. The combination of accessible rehabilitating
patients and modern transcriptomics and genomics of different
tumor types can address the open questions relating to ChHV5’s
oncogenic role, while novel environmental DNA (eDNA)
approaches can help resolve the dynamics of viral shedding and
transmission.
Environmental DNA is a non-invasive forensics approach to
the extraction and identification of organismal DNA fragments
(genetic material) released into the environment, and this rapidly
advancing approach is capable of improving endangered species
detection and early pathogen detection52–61. Environmental
samples can be analyzed for micro- and macro-organisms by
several eDNA methods including metabarcoding and species-
specific quantitative PCR (qPCR)55,57,62. The development of a
rapid and high-throughput sampling scheme to detect virus
shedding into the marine environment would benefit pathogen
surveillance efforts, and consequently the performance of wildlife
health status monitoring could be improved48,63. Here we applied
qPCR and shotgun sequencing (“unbiased”, non-barcoded)
eDNA approaches to temporally quantify ChHV5 viral shedding
from rehabilitating patients. Such novel approaches are a parti-
cularly beneficial feature of aquatic models of virally-induced
tumors, and will enable greatly improved understanding of the
dynamic relationship between viral load and viral shedding,
which is not readily measurable in terrestrial species.
We demonstrated previously that ChHV5 was transcriptionally
latent in a small cohort of seven established external FP tumors5.
We postulated that ChHV5 might be latent in established tumors,
but more active during crucial early stage tumor initiation events,
akin to the ‘hit and run’ hypothesis of viral oncogenesis5. To
investigate this hypothesis, we employed deep sequencing-based
transcriptomics and whole-genome sequencing (WGS) to deter-
mine the viral load and transcriptional status of ChHV5 across a
variety of FP tumor stages and presentations: new external,
established external, post-surgical regrowth external, internal
lung, internal urinary bladder, and internal kidney tumors.
Analysis of the host aspects of the current study’s transcriptomic
and genomic data are explored in a companion paper38. Here we
investigate viral dynamics during FP tumor growth, post-surgical
recurrence, and correlations between ChHV5 viral load and
ChHV5 gene expression with patient rehabilitation outcome to
identify characteristics relevant to disease severity and fate of
turtles afflicted with FP. Furthermore, we investigated potential
routes of transmission, primarily horizontal transmission by
direct shedding of ChHV5 into the water column, but also con-
firming the potential role of intermediary vectors and raising the
possibility of vertical transmission. Fibropapillomatosis
genomics29,31 and eDNA-based pathogen monitoring can reveal
the precise mechanisms through which the virus is transmitted
and the role of ChHV5 in host cell transformation and tumor
progression. Such research will provide insights into this wildlife
epizootic and reveal how ChHV5 can rapidly induce novel cancer
incidence on an epidemic scale. Such information is vital to
enable improved management, treatment, and mitigation strate-
gies to be developed to combat this sea turtle conservation-
relevant disease epizootic.
Results
High prevalence of ChHV5 in marine leeches feeding on FP-
afflicted turtles. A number of potential routes for ChHV5
transmission between sea turtles have been postulated, including
via vectors such as Ozobranchus leeches51. These marine leeches
are commonly found on FP-afflicted turtles, often at high density
within the crevices of external FP tumors (Fig. 1a, b). In line with
previous studies51, we confirmed that ChHV5 could specifically
be detected from DNA extracted from leeches that had fed on FP-
afflicted turtles (Fig. 1c–e). All leech pooled samples removed
from FP tumors tested positive for ChHV5 DNA (Fig. 1c, d),
while half of the leeches removed from non-tumor locations of
FP-afflicted animals were ChHV5 positive (Fig. 1c). Of 30 leeches
from FP tumors assessed individually (one DNA extraction per
whole leech), 90% were positive for ChHV5 (Fig. 1e). The 3
leeches that tested negative for ChHV5 (Fig. 1e) had smaller
(barely visible) blood pellets than the other 27 leeches. Leeches
removed from FP-free animals did not test positive for ChHV5
(Fig. 1c).
Detection of ChHV5 shedding into the water column by
environmental DNA (eDNA) approaches reveals novel
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shedding dynamics and tumor burden correlations. Another
potential mode of transmission is direct ChHV5 shedding into
the environment. Direct viral shedding as a route of transmission
is thus far only supported by indirect evidence, i.e., cloacal swabs,
urine, ocular, oral, and nasal secretions49,50,64, viral inclusion
bodies near the surface of external tumors48 and the elevated
levels of ChHV5 detected in bladder tissue (see below). Direct
detection of ChHV5 in the water column is lacking. Therefore, we
employed environmental DNA (eDNA)-based approaches cou-
pled with qPCR and next-generation sequencing to detect
ChHV5 in patient tank water. Such novel approaches can aid in
answering previously intractable questions about direct ChHV5
transmission, such as presence, abundance, and persistence in the
marine environment. First, we determined that the presence of
ChHV5 could be readily detected in eDNA extracted from tank
sea water, using either an established37 UL30 qPCR assay (Fig. 2a)
or next-generation sequencing (see WGS section below). ChHV5
was detectible not only from patient tank water, but also from
sand after a turtle lay on it for 30 min while awaiting treatment
procedures (Fig. 2b).
Importantly, not only was ChHV5 detectible, it was quantifi-
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time (Fig. 2a–f). The level of detectible virus in patient tank water
was positively correlated to the tumor burden of the patient(s)
housed in that tank (Pearson correlation coefficient test, R2=
0.5431, p= 0.0002, df= 19) (Fig. 2a). Patients with large well-
established tumors shed more virus into tank water than those
with small new-growth tumors. Larger tumors shed more ChHV5
by virtue of their cumulative size, not because they contain more
lytic ChHV5 per unit area than new growth tumors (see
transcriptomics section below). As FP tumors were surgically
removed, the level of ChHV5 in patient tanks dropped (Fig. 2c–e),
suggesting that the tumors are the primary source of
environmental ChHV5 (either through direct tumor shedding,
or migration of virus throughout the body and excretion in bodily
fluids). The level of ChHV5 in tank water of patients with high
tumor burdens was higher than that seen in leeches feeding on FP
tumors (Figs. 1c–e, 2a,c–e). Additionally, the quantity of ChHV5
eDNA in tank water was positively correlated with the C. mydas
(green turtle) eDNA level (Pearson correlation coefficient test, R2
= 0.66, p= 0.00001, df= 19), as detected by a custom
C. mydas 16S rRNA DNA assay (Fig. 2f). ChHV5 eDNA was
also detectible in the saltwater fishpond (approximate size 661,000
liters, Supplementary Fig. 1a) which receives the filtered outflow
sea water from our patient tanks (Supplementary Table 1),
highlighting ChHV5’s potential persistence in aquatic
environments.
ChHV5 is latent in FP tumors, including early stage, regrowth,
and internal tumors. While further investigation of the genomic
and environmental drivers of FP, and ChHV5 transmission is
warranted31, the suspected causal relationship between ChHV5
and FP also requires further study. Across all our sequenced FP
samples (RNA-seq), ChHV5 transcripts were low, and we
detected no major switch to active (lytic) virus in either new
growth FP or post-surgical regrowth FP (Fig. 3a). In fact, levels of
ChHV5 transcripts were only marginally (and not significantly)
higher in FP tumors than they were in non-tumor tissue controls
(Fig. 3a). The only significant difference found in the level of viral
RNA transcripts between any of the groups was between
regrowth and established growth external tumors
(Kruskal–Wallis with Dunn–Bonferroni post hoc, p= 0.013).
Furthermore, we detected no switch to active (lytic) viral tran-
scription in internal tumors (Fig. 3a). Supporting the paucity of
lytically replicating virus, no inclusion bodies were detected in
either internal or external tumors (Supplementary Table 2) by
hematoxylin and eosin staining (Fig. 3b). Together this suggests
that the role of lytic ChHV5 in FP is minimal and that if ChHV5
is contributing to FP oncogenesis, it is either (i) occurring tran-
siently, during very early tumorigenesis (before visible tumor
appears), or (ii) through the expression of ChHV5 miRNAs (not
assessed here), or (iii) that it is the latently expressed ChHV5
transcripts that are driving oncogenesis. We therefore next
examined the individual gene level transcripts to determine which
ChHV5 genes were transcriptionally active in FP tumors (albeit at
relatively low levels). Samples were grouped into four types: non-
tumor, external FP (including established, new growth, and
regrowth), kidney FP, and lung FP (Supplementary Data 1).
Across all four sample types quite a consistent pattern of ChHV5
gene expression emerged (Fig. 3c, Supplementary Fig. 1b), with
only 22 of ChHV5’s 104 genes showing levels of expression above
1 transcript per kilobase million (TPM, Supplementary Data 2).
Latency-associated genes, such as F-LANA formed part of this 22
gene group, being consistently expressed across all tumor types
(Fig. 3c and Supplementary Fig. 1b). Given the paucity of lytic
ChHV5, these 22 ChHV5 genes represent the most likely viral
drivers able to contribute to FP initiation and ongoing tumor
development and growth; therefore they warrant further func-
tional investigation.
Higher ChHV5 viral transcription is not indicative of poor
outcome. Almost all samples with ChHV5 viral reads above 200
per 10 million total reads originated from just three patients
(Supplementary Fig. 2a). Interestingly all three of these higher
viral transcript patients were successfully rehabilitated and
released. We, therefore, investigated whether there was any
relationship between number of viral transcripts and rehabilita-
tion outcome. Counter-intuitively, patients with positive outcome
(survived and released) on average had samples with statistically
significantly higher ChHV5 transcripts (Mann–Whitney U Test,
p= 0.03), while those patients that died in care or were eutha-
nized due to advanced disease actually had lower ChHV5 tran-
scripts (Fig. 4a). Even when internal tissue samples were removed
from the analysis (as all internal samples originated only from the
deceased/euthanized category), there remained a significant viral
expression difference between the two outcome groups
(Mann–Whitney U Test, p= 0.0143).
We next assessed whether individual viral genes correlated to
patient outcome. Twenty-one genes were significantly differen-
tially expressed between tumors from poor outcome (died or
euthanized) and good outcome patients, all of which were
upregulated in poor outcome tumors (Table 1). However, on
closer examination of the poor outcome tumors, it was
predominantly viral expression in internal tumors rather than
external tumors that was responsible for this differential
expression (Table 1 and Fig. 4b, c). Interestingly, the four
ChHV5 genes which are atypical of alphaherpesvirus, F-lec1, F-
lec2, F-sial, and F-M0465, were more highly expressed in internal
tumors (Table 1 and Supplementary Fig. 2b). These four genes are
postulated to play a role in viral immune evasion and viral
pathogenesis65. Of all of the differentially expressed ChHV5
genes, both genomic copies of the latency-associated F-LANA
gene showed the largest fold increase in expression in internal
tumors (Table 1 and Fig. 4b).
Fig. 1 Leech ChHV5 detection. a Green sea turtle inguinal external FP tumor, infested with leeches. Upon patient intake FP-afflicted tumors frequently
harbor marine leeches, as was the case for this patient 02-2021-Cm “Broccoli”. Leeches from “Broccoli’s” tumors were used for the ChHV5 analysis in (e).
Leeches are commonly found within the crevasses of external FP tumors (right image). b Detailed view of a marine leech removed from the surface of a
fibropapillomatosis tumor, with gills and with dark red blood pellet (after feeding on a C. mydas turtle) visible. c Detection and quantification of ChHV5
UL30 gene DNA by qPCR, using leeches as proxy eDNA samples (whole leech lysis and DNA extraction). Error bars denote the standard deviation of three
technical replicates. Amplification ratio for leeches from the FP-free loggerhead turtle (09-2015-Cc) was 0, and the amplification ratio for both the FP-
tumor leech and FP-tumor tissue samples (green turtle, 07-2015-Cm) was 1.0. d Quantification of ChHV5 UL30 gene DNA by qPCR, from leeches removed
from FP-afflicted green turtles from either FP tumors or non-tumor locations. Individual turtle denoted by rd—36-2020-Cm “Richard Dawkins”, bh—52-
2020-Cm “Bruno Hofer”, or rg—78-2020-Cm “Ruth Gates”. Approximately ten leeches were pooled for each of the 12 DNA extraction samples. Error bars
denote the standard deviation of six technical replicates. e Quantification of ChHV5 UL30 gene DNA by qPCR, from leeches (individual leech DNA
extractions) removed from FP tumors of green sea turtle patient 02-2021-Cm “Broccoli” (a). Amplification ratios for leech samples are provided in
Supplementary Table 1. Error bars denote the standard deviation of six technical replicates.
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Fig. 2 Environmental DNA (eDNA)-based detection, quantification, and monitoring of ChHV5 viral shedding into patient tank water, and sand. a
Correlation of individual patient tumor surface area (mm2) and the concentration of ChHV5 virus being shed into their tank water, as detected by ChHV5
UL30 gene DNA qPCR (positive correlation, Pearson correlation coefficient test, R2= 0.5431, p= 0.0002, df= 19). Water containing virus schematic insert
was generated using BioRender (https://biorender.com/). b Detection of ChHV5 viral shedding onto sand which a patient (“Archie Carr” 49-2020-Cm)
temporarily lay on while awaiting treatment. Detection of ChHV5 UL30 gene DNA by qPCR. Amplification ratios for each sand sample are provided in
Supplementary Table 1. Error bars denote the standard deviation of six technical replicates. c Patient time-course of tumor surface area changes (surgical
removal) and concentration of ChHV5 shed into tank water, as detected by UL30 qPCR. d Time-course of ChHV5 viral shedding into four patient tanks, as
detected by UL30 qPCR. Tumor removal surgery events are denoted by an asterisk. Note: the ChHV5 eDNA detected in tank 1 in week 4 was due to a
second patient (FP-positive) being added to that tank for a single week, due to the rehabilitation needs of the hospital. Error bars denote the standard
deviation of three biological samplings, each with three qPCR technical replicates. e Prolonged patient time-course of tumor surface area changes (surgical
removal) and concentration of ChHV5 shed into tank water, as detected by UL30 qPCR. f Correlation of Chelonia mydas (green sea turtle) eDNA shedding
and ChHV5 eDNA shedding (positive correlation, Pearson correlation coefficient test, R2= 0.66, p= 0.00001, df= 19), both C. mydas (16S rRNA gene
assay) and ChHV5 (UL30 gene assay) eDNA were detected by qPCR.
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High ChHV5 viral loads predominantly arise from latent virus.
Given the consistently low level of ChHV5 transcripts in FP
tumors, we next used whole-genome sequencing (WGS/DNA-
seq) to quantify the viral load of ChHV5 to determine whether
the low number of transcripts arises due to a lack of virus, or
whether large quantities of virus are present within FP tumors
with the majority of these being latent (not undergoing active
viral replication and transcription). By not conducting any viral
enrichment steps, the resulting read numbers give a more reliable
indication of the relative abundance of viral DNA compared with
host DNA (all within a single sample/library). Viral DNA
sequencing reads in the FP tumors covered a broad range
(Fig. 5a). Interestingly, the tank water eDNA had a higher viral
load than plasma and non-tumor tissue from FP-afflicted turtles
(Fig. 5a and Supplementary Fig. 2c). The lung and kidney tumor
samples from the same patient (patient 27-2017-Cm) had dra-
matically different viral loads (Fig. 5a, Table 2). The six tumors
(external and kidney) from patient “Yucca” (49-2019-Cm) had a
range of ChHV5 reads per 10 million total reads (RPTM) from
1198 to 3127 RPTM. The new growth FP tumor from the patient
“Lilac” (25-2018-Cm) had an intermediate viral load of 1,036
RPTM (Table 2 and Fig. 5a). Other new growth tumors from
“Lilac” also showed high viral loads (Fig. 5b). Despite the high
level of ChHV5 DNA sequencing reads in the lung tumor (3673
RPTM), this same tumor only had a very low level of ChHV5
RNA sequencing reads (68 RPTM), more closely resembling the
read numbers of the non-tumor tissues (Table 2).
The kidney tumor from patient 27-2017-Cm had minimal viral
load (Table 2 and Fig. 5a) and this same tumor had minimal copy
number variations in the host tumor genome30, suggesting that
the tumor must be driven by other oncogenic mechanisms, such
as point mutations, epigenetic changes, or transcriptional/
translational aberrations. The viral load of this kidney tumor
was within the range of non-tumor tissues (juveniles and
hatchlings) and plasma from FP-afflicted turtles (Fig. 5a).
When DNA-based viral reads (Fig. 5a) were compared with viral
reads from the RNA transcripts (Fig. 3a) of the 90 RNA-seq



















































































Fig. 3 Transcriptomics of ChHV5 in external and internal FP tumors, and non-tumor tissue samples. a ChHV5 expression across each sample type. Box
plot with Tukey whiskers of the number of ChHV5 reads (RNA-seq) per 10 million total reads per sample. Individual sample values within each sample type
are shown by the open points. Significant differences in averages between sample types were determined by a Kruskal–Wallis with Dunn–Bonferroni post
hoc test and are denoted by an asterisk (*). Per sample type: non-tumor n= 20, established external tumor n= 35, regrowth external tumor n= 12, new
growth external tumor n= 9, kidney tumor n= 6, lung tumor n= 7. b Top: Rehabilitating FP-afflicted juvenile green sea turtle. Image credit: Nancy
Condron. Bottom: Hematoxylin and eosin stained fibropapillomatosis tumor, external regrowth tumor. c Total number of samples in which reads (RNA-
Seq) for each ChHV5 gene were detected. A gene was counted as detected if a sample had TPM-normalized counts >0 for said ChHV5 gene.
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Fig. 4 Patient rehabilitation outcome and ChHV5 gene expression. a Box plot with Tukey whiskers of the number of ChHV5 reads (RNA-Seq) per 10
million total reads between patients based on outcome (released vs died in care/humanely euthanized). Individual sample values within each sample type
are shown by the open points. Significant difference in averages between the two outcomes was determined by a Mann–Whitney U test and is denoted by
an asterisk (*). N= 69 samples. Per outcome: released= 7 turtles; died/euthanized= 5 turtles. b Box plot with Tukey whiskers of the expression levels of
the ChHV5 F-LANA genes (both copies of the F-LANA gene: F-LANA and F-LANA’) in transcripts per million (TPM), by patient outcome and tumor
location, as detected by RNA-seq. Individual sample values within each sample type are shown by the open points. c Principal component analysis (PCA) of
the viral transcriptomes (minus 28 genes which had 0 reads across all samples, see methods) of all tumor samples (RNA-seq), by tumor location and
patient outcome.
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(one FP and one non-tumor sample), while the highest viral DNA
load observed was 3,673 RPTM. Interestingly, a high viral DNA load
did not equate to high viral transcription (RNA) in the same sample
(Table 2). As expected, WGS reads were dispersed across the entire
ChHV5 genome (Supplementary Fig. 3a), not being restricted to
ChHV5’s transcriptionally active regions (Supplementary Fig. 1b).
This confirms that the limited transcriptional signature is not due to
a sequencing artifact. Together, the ChHV5 genome-level and gene-
level TPM analysis highlight the marked difference in reads between
viral DNA presence and viral RNA transcription in FP tumors.
Conversely, the range of viral DNA and viral RNA within non-
tumor tissue was largely overlapping suggesting that the ChHV5
present in non-tumor samples may be more likely to be
transcriptionally active (Table 2 and Figs. 3a, 5a).
Lung and urinary bladder tumors tend to have high viral loads.
We next examined the ChHV5 viral loads (viral DNA-based
qPCR, ChHV5 UL30 assay) in a wider cohort of internal tumor
and matched non-tumor tissue types. Liver and kidney FP tumors
had consistently lower viral loads than was seen in other tumor
types, although wide ranges in ChHV5 loads were observed in
other tumors (Fig. 5c), and some sequenced kidney tumors (all
three from patient “Yucca”) had high viral loads (Fig. 5a). Lung
and urinary bladder FP tumors consistently had the highest viral
loads (Fig. 5c), while, of the non-tumor tissue types assayed,
bladder tissue also showed high viral loads, with detected levels
being higher than in some of the FP tumors (Fig. 5c).
ChHV5 may be vertically transmitted from mother to off-
spring. Interestingly, the range of ChHV5 detected in hatchlings
(one C. mydas, one loggerhead [Caretta caretta] and one lea-
therback [Dermochelys coriacea]) overlapped the range of ChHV5
in FP-afflicted non-tumor tissue, the FP kidney tumor, and FP-
afflicted blood plasma samples (Fig. 5a). Of the three species, the
leatherback sample had the highest number of ChHV5 reads,
with many reads aligned to non-coding regions of the ChHV5
genome (Fig. 5a and Supplementary Fig. 4a). ChHV5 DNA was
also detected at low levels in six samples from a number of tissues
(eye lid, neck, cloaca, front flipper, and heart) from a deceased
unhatched green sea turtle (Supplementary Fig. 4b), using the
ChHV5 UL30 qPCR assay (viral DNA range: 0–2.24E−05 pg/μl.
Amplification ratio: 0.125). No ChHV5 DNA was detected from
samples of brain, yolk, and intestine from this turtle.
WGS reveals no evidence of papillomavirus (PV1) association
with FP tumors. We used our unbiased WGS to assess whether
green turtle or loggerhead specific papillomaviruses (CmPV1 and
CcPV1) were present in any of our samples, as although present
in sea turtles CmPV1 and CcPV1 have not been strongly asso-
ciated with FP tumors66–68. No CmPV1 reads were detected in
any tumor samples, skin samples or plasma samples of FP-
afflicted turtles (Supplementary Table 3). Furthermore, unlike
ChHV5 (Fig. 3a), no shed CmPV1 or CcPV1 was detected in tank
water of pooled FP-afflicted juvenile green and FP non-afflicted
loggerhead hatchlings (Supplementary Table 3). From all
38 sequenced samples only two reads were detected for CcPV1,
both in C. mydas kidney FP tumors from different individuals
(Supplementary Table 3). This might be an artifact as the mate
pair of these reads (paired-end sequencing), did not align to
CcPV1. These two kidney tumors had 75 and 3,127 ChHV5
RPTM respectively (Table 2 and Supplementary Data 1), but only
0.037 and 0.014 CcPV1 RPTM respectively (Supplementary
Table 3). Therefore, our WGS provides no evidence for a corre-
lation between the presence of CmPV1 or CcPV1 and FP tumors,
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Discussion
Anthropogenic activities are fueling the acceleration of the sixth
mass extinction event69, and human-wildlife conflict and inten-
sive farming pressure are facilitating zoonotic disease pandemics
(such as Ebola, SARS, and COVID-19) with the transmission of
animal viruses to humans29,70–74. While the rapid environmental
changes induced by human activities are increasing viral trans-
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consequences of infections in animal populations, which are more
susceptible to disease in the absence of healthy habitats and
natural population sizes and ranges with their associated robust
genetic variation29. Anthropogenic activities are likely increasing
cancer rates in wild populations75,76, with increased incidence
and range of sea turtle fibropapillomatosis appearing to be a
direct result of human activities impairing the ability of inshore
juvenile sea turtles to combat the ChHV5 virus3,31,77. However,
studies establishing functional links between environmental
contaminants and fibropapillomatosis tumorigenesis, especially
across large spatial scales, are required.
It is thought that environmental changes are key to conferring
oncogenicity upon ChHV5, potentially through compromising
the immune system of sea turtles3,10,78,79. While hosts attempt to
mount an immune response30 tumors still develop in a large
proportion of individuals3,5,9. The causal link between ChHV5
and fibropapillomatosis also requires further scrutiny. As revealed
here, either the role of ChHV5 in driving FP tumor formation
and progression is restricted to extremely early tumorigenesis
events, or it is driven by latently expressed genes, or is overstated.
As a number of ChHV5 strains exist, it was initially hypothesized
that some strains were more oncogenic than others, thus accounting
for differences of the severity of FP disease between individuals and
populations. However, it has consistently been shown that different
ChHV5 strains bear no correlation to disease severity3,41,44,46,80,
although large scale geographic differences do exist.
Similar to smaller cohorts of external FP tumors assessed by
RNA-seq5,81, we found no evidence to support widespread lytic
ChHV5 viral replication within any of the tumor types profiled here.
This includes early stage new growth tumors, suggesting that the
viral ‘hit and run’ hypothesis82 of oncogenic transformation does
not apply to fibropapillomatosis tumors, or that if it does it must be
extremely temporally restricted, likely before a visible tumor devel-
ops. Furthermore, our results reveal that if ChHV5 is responsible for
inducing de novo tumor formation in internal organs, then the
limited expression and load of ChHV5 in some internal tumors is
highly irregular, particularly in kidney and liver tumors. That even
tumor samples with high ChHV5 loads (DNA-level) have only low
ChHV5 gene expression (RNA-level), suggests that rapid prolifera-
tion of host tumor cells infected with latent virus is the primary
driver of the high viral loads sometimes observed in FP tumors.
Fibropapillomatosis cell proliferation can be rapid and tumors can
double in size in less than two weeks1. Similarly, the paucity of
elevated levels of viral transcripts across all tumor samples, in
addition to the lack of inclusion bodies, suggests that lytic virus may
not be driving the establishment of numerous primary tumors
within the same individual. The presence of inclusion bodies in FP
tumors is relatively rare. In one study, from the analysis of 381 FP
tumors from 17 individuals, epidermal intranuclear inclusion bodies
were only identified in 35% of FP-afflicted individuals, and even
within that subset of individuals, only 7% of their tumors contained
at least one inclusion body48. Similarly, in situ hybridization of the
ChHV5 UL30 gene only detected expressed ChHV5 transcripts in
three out of 25 tumors83. Even within those three tumors, there was
only a low level of expression which was spatially restricted83.
Processes occurring in the dermis (especially relating to fibroblasts)
may also influence the development of tumors and host-viral
interactions, as FP tumors involve changes to both epidermal and
dermal cells. Our whole-genome viral transcriptomics confirms that
lytic ChHV5 gene expression is lacking in both external and internal
tumors. Even while in their latent stage oncogenic viruses can
manipulate host cell signaling and contribute to oncogenic trans-
formation and tumor development84–86.
Counterintuitively, we show that animals with lower overall
viral transcriptional expression had worse rehabilitation out-
comes than those with higher viral transcription. Oncogenic
viruses can use latency as an immune avoidance strategy, with
bouts of temporally and spatially restricted lytic activity helping
to prevent a largescale immune response. This feature of onco-
genic viruses may help to explain why ChHV5 is predominantly
latent in FP tumors, and why lytic viral replication is so spatially
restricted48,83. In this context, FP tumors with higher ChHV5
expression levels may be more prone to inducing immune
responses, leading to improved patient outcomes. Further sup-
porting this hypothesis, we recently showed that, in the same
Fig. 5 Variation in ChHV5 DNA load across tumor and non-tumor tissue types, as assessed by whole-genome sequencing and qPCR. a ChHV5
abundance (WGS DNA-based) across each sample type. Graph of the number of ChHV5 reads (DNA-seq) per 10 million total reads of 35 samples, with
Tukey whiskers. Per sample type: external fibropapillomatosis tumor n= 7, internal fibropapillomatosis tumor n= 6 (4 kidney FP, 1 bladder FP and 1 lung
FP), non-tumor n= 8 (2 skin, 2 kidney, 1 bladder, 1 lung, and 2 whole blood), plasma from FP-afflicted turtles n= 10, tissue from non-tumor hatchlings n= 3
(1 green, 1 loggerhead, and 1 leatherback), tank environmental DNA (eDNA) n= 1 (pooled sample of eDNA from 4 tanks with FP-afflicted juvenile green
patients and 1 tank with FP-free loggerhead hatchlings). P-values for all groups with significant differences (t-test) to the non-tumor (skin and whole blood)
sample cohort are shown on the graph. All samples are from green sea turtles, with the exception of two of the hatchling samples (loggerhead and
leatherback), and the eDNA tank sample being pooled from four green and one loggerhead tank water extractions (Supplementary Fig. 2c). b Image of new
growth tumors on patient “Lilac” (25-2018-Cm). “Lilac” was admitted to the hospital without tumors, but with a number of leech bites which later
developed into FP tumors. ChHV5 relative quantification of “Lilac” new growth tumor samples and non-tumor skin punch biopsy samples using the UL30
DNA qPCR assay37 (Supplementary Table 6). Error bars denote the standard deviation of three qPCR technical replicates. ChHV5 DNA was detected in
these growths via qPCR prior to them being classified as fibropapillomatosis by histology. c ChHV5 viral quantification box plot with Tukey whiskers of a
range of FP types (n= 43 samples) and non-tumor tissue (n= 36) samples from 13 individual patients using the UL30 DNA qPCR assay37 (Supplementary
Table 6). Individual sample values within each sample type are shown by the open points. Absolute quantity of ChHV5 was determined through a standard
curve of known amounts (in picograms) of a UL30 gene fragment (Supplementary Table 6). Truncated x-axis label, internal sub-cutane.= internal sub-
cutaneous.
Table 2 Comparison of viral sequencing reads per tumor and
non-tumor tissue at the DNA and RNA level, for patients 27-






Lung FP tumor 3673 68
Lung non-tumor 68 36
Kidney FP tumor 75 30






Skin non-tumor 81 —
Number of reads per 10 million total reads (RPTM) are shown for each sample.
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patient cohort used in this study, higher expression levels of
immune-related host genes were associated with better patient
outcomes38.
The latency-associated gene LANA and the four atypical
ChHV5 genes (F-lec1, F-lec2, F-sial, and F-M04)65 were more
strongly expressed in internal tumors than external tumors,
although overall expression levels were relatively low. The dif-
fering ChHV5 gene expression profiles between internal and
external FP tumors, suggests that the mechanisms driving inter-
nal tumor development are different from those driving external
tumor development. Supporting this, we recently showed that the
host oncogenic signaling events driving internal and external
tumor development also differ dramatically38.
Sea turtle papillomaviruses (CmPV1 and CcPV1) were originally
described in non-FP proliferative skin lesions66,67. However, a
subsequent report described papillomavirus in cell lines derived
from FP tumors and postulated that they may be associated with
sea turtle fibropapillomatosis tumors68. Fibropapilloma tumors are
associated with papillomaviruses in other domesticated and wild
species87–89, as well as a variety of human cancers, including cer-
vical, and head and neck cancer90,91. However, it remains to be
resolved whether papillomaviruses have any correlation to FP
tumor occurrence. Using qPCR, CmPV1 was recently detected in
skin tumor samples (<10 tumors) of Australian C. mydas, while
cloacal swabs, blood, and normal skin samples from the same
animals tested negative68. However, when we assessed for the
presence of PV1 by WGS we detected no CmPV1 in tumor sam-
ples, skin samples, blood plasma or tank water. While a greater
number of individuals and locations should be assessed, we found
no evidence for PV1 as a causative or even correlative factor to sea
turtle fibropapillomatosis, despite the prominent role of papilloma
viruses in papilloma tumors of other species87–91. Given their small
genome and ability to induce oncogenesis at lower loads than
herpesviruses, targeted qPCR approaches should also be employed,
to confirm whether papillomaviruses are absent from FP
tumors68,92. Recently, such approaches detected PV1 in 47% of FP
tumors in Australia93.
ChHV5 DNA was identified in C. mydas, loggerhead (Carretta
carretta), and leatherback (Dermochelys coriacea) hatchlings, and
their abundance overlapped the range (no significant difference)
seen in non-tumor tissue and blood plasma from FP-afflicted
turtles, and an FP kidney tumor. Although it should be noted that
ChHV5 genome coverage was not as complete in these hatchling
samples as for tumor samples (Supplementary Fig. 4a). ChHV5
DNA was also detected at low levels, by qPCR, in a pre-hatchling
that died prior to successfully hatching. A key objective should be
to confirm whether vertical transmission of the virus occurs from
mother to offspring. This hypothesis conflicts with the pre-
dominant hypothesis that ChHV5 infection is acquired only after
juvenile turtles recruit to nearshore habitats46,94. If widespread
vertical transmission is confirmed, the relative contribution of
vertical versus horizontal transmission needs to be determined. If
hatchlings are already infected with ChHV5 (vertical transmis-
sion), this has serious implications for any potential population-
level vaccination-based mitigation strategies. On-beach
(immediate nest emergence95) sampling and qPCR and
sequencing-based ChHV5 detection should be conducted to
confirm this finding and to determine the prevalence of ChHV5
infected hatchlings. Non-invasive sampling of sand from nest
chambers may also reveal whether ChHV5 is present, given that
we could detect ChHV5 from sand samples exposed to FP-
afflicted patients.
In terms of horizontal vector-borne transmission, we show that
ChHV5 was detectible in 90% of leeches removed from FP
tumors, this contrasts to a reported 27.5% of leeches from FP-
afflicted turtles testing positive for ChHV596. This difference
likely arises from relatively rapid testing (3 days to 7 months) in a
rehabilitation setting, as opposed to the historical frozen sample
set that was used for the Rittenburg et al. 2021 study96. Leeches
likely only represent a mechanical vector of ChHV5 transmission,
as studies to determine whether leeches function as a true vector
with ChHV5 replicating within leeches (as an intermediary host)
have not yet been conducted. While a broad range of ChHV5
quantity was detected across leech and patient tank water sam-
ples, ChHV5 tended to be more abundant in the water column
than in marine leeches. This suggests that both direct water-borne
transmission, and vector-borne transmission of ChHV5 are likely.
Accurate detection and monitoring of wildlife pathogens (both
vertical and horizontal transmission) with the capacity to impact
species survival is essential to devise and implement appropriate
mitigation policies63. Environmental DNA approaches have been
shown to detect aquatic pathogens earlier than traditional
methods and provide advanced warning of infection and mass
mortality events57,63. Our eDNA-based detection of ChHV5 in
sea water is particularly significant given that, unlike more
immediate acting pathogens, for virally-induced cancers there is
generally a long lag time (years or decades) between infection and
tumor formation97–99. It has previously been asserted that only a
small percentage of FP tumors shed virus (7% of tumors in 35%
of individuals)48. However, our eDNA-based monitoring of viral
shedding demonstrated that ChHV5 could be detected even in
the tanks of turtles with low tumor burdens and that
ChHV5 shedding positively correlated to tumor burden. Other
disease-associated green turtle herpesviruses have been shown to
remain infective after exposure to sea water, though this has not
yet been assessed for ChHV5100. Our findings regarding the
predominance of latent ChHV5 within fibropapillomatosis would
suggest that not all viral DNA in patient tank water may derive
from lytically produced virus. Future studies should determine
what proportion of detectible ChHV5 eDNA in patient tanks is
derived from viral DNA within host cells compared with free
viable infective virus. That urinary bladder samples had high viral
loads has potential implications for the spread of ChHV5, as
urine is another potential source of ChHV5 release from the body
and transmission49,50.
In the near future, eDNA technologies57,63 may allow for the
early detection of ChHV5 presence in the environment of vul-
nerable populations (akin to our detection of ChHV5 in the larger
fishpond), and enable further research into the etiology, host
species transmission and disease ecology of FP. This unique tool
to dynamically track environmental viral shedding in response to
disease progression and clinical interventions such as surgery and
drug treatment will greatly enhance our ability to address fun-
damental questions relating to this disease, as well as to design
evidence-based rational management strategies (e.g., contain-
ment/isolation policies). The approach can also be used for reg-
ular or intermittent monitoring of tank water in captive turtle
populations, for early warning and disease prevention strategies.
Such approaches can also improve our understanding of how
environmental and clinical factors influence viral release and
spread. The ability to perform eDNA-based quantitative viral
shedding monitoring will also further enhance the utility of FP as
a model not just to better understand this wildlife epizootic, but
also to address unresolved questions relating to viral shedding for
other animal and human pathogen-induced cancers.
Summary. Taken together, our results provide transcriptome and
genome-level profiling of ChHV5 across external, new growth,
established, post-surgical regrowth, and internal visceral tumors
(Table 3). They reveal the paucity of lytic ChHV5 replication
within tumors, even those harboring high viral loads. High viral
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loads, where they do occur, likely represent latent virus being
produced as infected tumor cells rapidly proliferate. They also
revealed that a number of tumors, particularly some internal
types, have extremely limited viral loads (DNA-based assess-
ment), calling into question the role of ChHV5 in the establish-
ment and growth of these tumors. The application of novel
eDNA-based pathogen monitoring revealed that ChHV5 is shed
into the water column, and quantification of ChHV5 eDNA
revealed that the level of virus in patient tank water correlates to
patient tumor burden. ChHV5 shedding is prevented upon
excision of fibropapillomatosis tumors. Improved understanding
of the oncogenic role of ChHV5 and its transmission can inform
population management and clinical management strategies,
including informing biosecurity and quarantine practices.
Methods
Tissue sampling. Sampling was carried out under permit number MTP-21-236
from the Florida Fish and Wildlife Conservation Commission and with ethical
approval from the University of Florida’s Institutional Animal Care and Use
Committee (IACUC). External fibropapillomatosis (FP) tumors were surgically
removed by laser resection as part of the turtle’s rehabilitative care or obtained
during necropsy5. Non-tumored areas of the same turtles were obtained by 4 mm
punch biopsies during the tumor removal surgery, or during necropsy. Non-
tumored sites were selected by gross examination of the region by the attending
veterinarian and confirmed visually to be tumor-free normal skin regions and not
bordering any tumorous regions by the attending vet, technicians, and researchers.
External tumors were sampled from a range of body locations, including skin,
plastron, and eye tumors (Supplementary Data 1). Internal tissue samples (tumors
and non-tumor tissue samples from lung, kidney, bladder, liver, mouth, sub-
cutaneous, and heart) were obtained from animals during necropsies conducted
immediately after euthanasia. Note that no animal was euthanized for the purposes
of this study, but rehabilitating sea turtles found to harbor internal tumors are
currently euthanized in Florida, according to Florida Fish and Wildlife Con-
servation Commission protocols, as no treatment yet exists for internal tumors.
Additional complications arising from surgery and other health concerns may also
sometimes necessitate the humane euthanization of sea turtles in rehabilitation.
Internal tissue samples were treated the same as the external samples. All samples
were obtained from juvenile C. mydas, as this life stage is the most commonly
afflicted by the disease. Sex is not readily determinable in juveniles, but was pro-
vided for individuals that were euthanized due to internal tumors or other com-
plications and in which necropsies were performed, or for individuals that were
endoscoped (KARL STORZ, Multi-Purpose Rigid Endoscope for small animals) as
part of their rehabilitative care (see Supplementary Data 1). Samples were stored in
RNA-later (Qiagen) at −80 °C, according to the manufacturer’s instructions, until
extraction. Samples were stored between <1 day and 8 months, with 85% of
samples being extracted within one month.
For the three hatchling samples (one green, one leatherback, and one
loggerhead) utilized for WGS, these were admitted to our rehabilitation hospital
but died in care. They were housed completely separately to FP-afflicted juvenile
patients and frozen at −20 °C upon death. Within two months the carcasses were
thawed and during necropsy a cross section of the front flipper of each hatchling
was used for DNA extraction (see below). This sampling was conducted using
sterile technique, with separate instruments (single use disposable), and was
conducted in a lab which never housed FP-patients or any patients from other size
classes. For the unhatched green sea turtle utilized for qPCR, upon death this
animal was necropsied (on the same day) and tissue samples were obtained from
Table 3 Summary of key study findings and their potential implications.
Key Points Implications
90% of leeches which feed on FP tumors harbor ChHV5 Marine leeches remain a potential viral vector, with the potential to infect
naive individuals, and must be considered in any mitigation strategies.
ChHV5 is detectable and quantifiable from sea water Direct transmission (without the need for intermediary vectors) is,
therefore, a likely possibility, with implications for management and
mitigation strategies both in rehabilitation facilities and wild populations.
ChHV5 levels in the water column correlate to tumor burden Tumors themselves are the predominant driver of viral load in patient
tank water. As tumors are surgically removed the level of ChHV5 in tank
water reduces.
ChHV5 is predominantly latent (whole transcriptomics) across new growth,
established, regrowth and internal tumors and lower ChHV5 gene
expression is associated with poor patient outcomes
Highly lytic ChHV5 is not likely driving crucial early stage tumor initiation
events, suggesting that the ‘hit and run’ hypothesis of viral oncogenesis5,
does not apply to FP.
Host genes are primarily responsible for driving tumor growth, suggesting
anti-viral drugs are unlikely to be an effective FP treatment strategy.
Atypical ChHV5 genes (F-lec1, F-lec2, F-Nec, F-Sial, and F-M04) are
more highly expressed in internal tumors, though genome-wide ChHV5
expression is lower.
High viral loads in FP tumors are primarily due to latent, not lytic, viral
replication
FP tumors with high ChHV5 loads (DNA-based detection), still have low
viral expression levels (RNA-seq).
Latency of ChHV5 may be an immune evasion strategy This immune avoidance strategy likely limits the potential of anti-viral
drugs as FP treatments, and reduces the capacity of host immune
systems to combat the infection. FP tumors with higher ChHV5
expression levels may be more prone to inducing immune responses,
leading to improved patient outcomes. Further supporting this
hypothesis, we recently showed that, in the same patient cohort used in
this study, higher expression levels of immune-related host genes were
associated with better patient outcomes38.
Hatchlings may already be exposed to ChHV5 The detection of ChHV5 at levels similar to or higher than those seen in
non-tumor tissue samples from FP-afflicted turtles suggests ChHV5
transmission may occur early in turtle lifecycles. The prevalence in
hatchlings and whether transmission is vertical (from mother), occurs in
nest, or upon emergence should be determined.
ChHV5 ‘super-spreaders/super-shedders’ are unlikely, rather larger tumor
volumes shed more virus into the water column
A higher tumor burden leads to more viral shedding, but this is driven
primarily by larger tumors producing a similar level of virus per area as
new growth tumors, rather than established tumors producing more lytic
virus per area of tumor. There is no significant shift towards lytic virus
production in established tumors, rather levels of lytic virus remain
relatively low, but the sheer increase in tumor volumes results in more
shedding. Therefore, any heavily burdened individual is likely to be
shedding large quantities of virus.
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the following locations; eye lid, neck, cloaca, front flipper, heart, brain, yolk, and
intestine, and DNA extracted immediately (see below). Prior to death, this turtle
remained in its shell and never encountered FP-afflicted turtles, areas, or
instruments.
Leeches were removed from six patients during routine admission exams and
stored in RNAlater (Qiagen) at −80 °C until extraction. Leeches used for pooled
leech extractions were stored for up to 7 months prior to extraction (from “Ruth
Gates”, 07-2015-Cm and 09-2015-Cm were stored for 1 month, from “Bruno
Hofer” for 5 months, and from “Richard Dawkins” for 7 month). Leeches used for
individual leech extractions (from “Broccoli”) were stored for 3 days prior to
extraction. Leeches were removed from FP tumors, from non-tumor sites (soft
skin/plastron) of FP-afflicted turtles, or from non-FP afflicted turtles. Each entire
leech (individual samples) or groups of approximately 10 entire leeches (pooled
samples, from the same location type) including the blood pellet were homogenized
and used for DNA-extraction (using a DNeasy Blood and Tissue Kit [Qiagen, Cat
No. 69504], see below). The majority of the leeches were removed from inguinal
regions (both tumor and non-tumor), all 30 leeches extracted individually were
removed from two FP tumors on patient “Broccoli’s” ventral inguinal region
(Fig. 1a).
RNA and DNA Isolation, library preparation, and sequencing from tissue and
eDNA samples. All sequencing was conducted at the University of Florida’s
Interdisciplinary Center for Biotechnology Research Core Facilities. For RNA-Seq
samples, total RNA was extracted using either an RNeasy Fibrous Tissue kit
(Qiagen, Cat No. 74704) or RNeasy Plus kit (Qiagen, Cat No. 74134) with column-
based genomic DNA removal, according to the manufacturer’s instructions. Ninety
RNA samples, comprising 70 FP tumor samples and 20 non-tumor samples from
12 juvenile green turtles which had stranded in Northern Florida, were used for
sequencing. Samples were further categorized by tissue type, as well as growth
profile for the external tumors only (see Supplementary Data 1). Sequencing
libraries were generated from 500 ng of total RNA using the NEBNext Ultra RNA
Library Prep Kit for Illumina (New England Biolabs, Cat No. E7530), including
polyA selection, according to manufacturer’s protocol. Size and purity of the
libraries were analyzed on a Bioanalyzer High Sensitivity DNA chip (Agilent). The
RNA samples used for library construction had a RIN value range of 7.2 to 9.8,
with the median RIN value of all samples being 9.1. Libraries were sequenced as
paired-end reads with a read length of 100 bp on a HiSeq 3000 (Illumina). ERCC
Spike-In Mix (ThermoFisher) was used as an internal control: 2 μL of 1:400 diluted
ERCC Spike-In Mix with 500 ng of total RNA input.
Fibropapillomatosis-afflicted juvenile C. mydas tissue DNA-seq samples were
sequenced in two batches, 6 initial samples on a HiSeq 3000, and 18 NovaSeq 6000
(Illumina) samples. For HiSeq 3000 samples, DNA was extracted using a DNeasy
Blood & Tissue Kit (Qiagen, Cat No. 69504). Libraries were generated using
Illumina TruSeq DNA PCR-Free Library Prep kit including fragmentation with a
Covaris S220 sonic disruptor. Size and purity of the libraries were analyzed on a
Bioanalyzer High Sensitivity DNA chip (Agilent). Libraries were sequenced as
paired-end reads with a read length of 100 bp on an Illumina HiSeq 3000. Six
whole genomic DNA samples, comprising three FP tumor samples and patient-
matched non-tumor samples from two juvenile green turtles which had also
stranded in Northern Florida, were used for sequencing. These samples were
further categorized by tissue type, with one tumor and patient-matched healthy
tissue sample each coming from an external, kidney, and lung tissue source (see
Supplementary Data 1). For NovaSeq 6000 samples (Supplementary Data 1), the 18
DNA samples were fragmented on a Covaris S220 sonicator, to generate ~300 bp
fragments. Fragmentation was followed by AMPure clean-up (0.9:1.0 beads:sample
ratio). The cleaned-fragmented material (50 ng) was used as input for library
construction. Sequencing libraries were constructed using the NEBNext UltraTMII
DNA Library Prep Kit for Illumina (Cat# E7645S), according to the manufacturer’s
protocol. A set amount of 10–20 ng of sample was used to barcode and generate full
adapter-ligated libraries through PCR. PCR was done for only 6–7 cycles of
amplification in order to minimize duplicate reads. Barcoding was done using the
indexing reagents provided in the NEBNext Unique Dual Index Oligos kit (Cat#
E6440S). The final libraries were quantified by fluorescence (QUBIT,
ThermoFisher), and sized on the Agilent TapeStation (DNA5000 Screen Tape). A
yield of 50–60 ng of library was obtained of an average size ranging from 460 to
600 bp. Libraries were normalized and pooled equimolarly. This step was followed
by treatment with the “Free Adapter Blocking Reagent” protocol (FAB, Cat#
20024145) in order to minimize the presence of adaptor-dimers and index hopping
rates. The library pool was diluted to 2.5 nM and sequenced (one S4 lane, 2 × 150
cycles [paired-end]) according to Illumina NovaSeq6000 sequencing protocol,
using 180 pM loading concentration and 1% PhiX spike-in control. Approximately
10 billion paired-end reads were obtained for the entire run (Q30% >= 80%;
Cluster PF= 70%), ~8.7 billion paired-end reads were generated (NovaSeq 6000)
for the 18 C. mydas samples, with the remainder of the reads relating to samples
from other projects.
In addition, whole genomic DNA was extracted from 10 plasma samples taken
from six individual turtles during the course of their rehabilitation (Supplementary
Data 1). Excess blood was utilized from blood samples drawn for routine medical
care by our veterinarians and plasma was separated from the red blood cells by
centrifugation. Only 100 µl of plasma was collected and stored as allowed by permit
number MTP-21-236 from the Florida Fish and Wildlife Conservation
Commission. DNA was extracted from 60 µl of plasma using a DNeasy Blood &
Tissue Kit (Qiagen, Cat No. 69504) and used to produce low input Illumina
Fragment libraries using a Low Input Library Prep kit v2 (Clontech Laboratories,
Inc., Catalog No. 634899). DNA was fragmented using the Covaris S220 sonic
disruptor and libraries were then sequenced as paired-end reads with a read length
of 100 bp on an Illumina HiSeq 3000.
Furthermore, three whole genomic DNA samples were also taken from ground
flipper tissue samples from three deceased hatchling turtles (never in contact with
FP-afflicted patients or water/tanks) of each separate species: a green (C. mydas),
loggerhead (C. caretta), and leatherback turtle (D. coriacea), and processed
following the methods for tissue (HiSeq 3000) as detailed above. The leatherback
sequence length was the only sample that differed, with paired-end reads of length
150 bp instead of 100 bp. TPM generation of hatchling samples was done using
viral aligning reads only, as not all of the turtle species have published reference
genomes.
Finally, one pooled library of environmental DNA (eDNA), combining five
holding tank water samples from the Whitney Laboratory Sea Turtle Hospital
facility of the University of Florida was also used for sequencing. For this pooled
sample, water collection, filtration, and extraction were performed separately on
each tank sample, and the final purified DNA was pooled prior to library
preparation. Pooling was conducted to obtain the average ChHV5 load across the
five tanks. Seawater from five tanks (four housing juvenile green sea turtles and one
housing loggerhead post-hatchling washbacks, 500 ml seawater per tank) was
filtered (EMD Millipore PES 0.22 μm Sterivex filter) by a hand pump and DNA was
extracted from the filter using a Qiagen DNeasy Blood & Tissue Kit (Qiagen, Cat
No. 69504) and modified extraction protocol was carried out58, with an overnight
(24–36 h) incubation of the filter at 56 °C in Buffer ATL and Proteinase K in a
hybridization oven with agitation. Libraries were generated using a NEBNext Ultra
II DNA Library Prep Kit for Illumina (New England Biolabs, Cat No. E7645),
including fragmentation with a Covaris S220 sonic disruptor. Fragment size and
purity of the libraries were analyzed on a Bioanalyzer High Sensitivity DNA chip
(Agilent). Libraries were sequenced as paired-end reads with a read length of 100
bp on an Illumina HiSeq 3000.
Quality control and read trimming. The software FastQC—https://www.
bioinformatics.babraham.ac.uk/projects/fastqc/—was used to assess data quality.
Reads were then trimmed with trim_galore (The Babraham Institute, version 0.5.0)
to remove ends with a Phred quality score less than 30, to remove adaptor
sequences, and to remove sequences fewer than 25 bp after trimming. For any
samples that contained overrepresented sequences according to FastQC, the
trimmomatic tool101 (version 0.36) was then used to remove these sequences from
reads and any sequences less than 25 bp after trimming. The number of raw reads
per sample and reads remaining after trimming can be found in Supplementary
Data 1.
Read alignment and read counts. Reads from all samples (RNA-seq, DNA-seq,
and eDNA) were first aligned to the ChHV5 genome [GenBank accession number:
HQ878327.2]65 to determine the level of ChHV5RNA and DNA present in each
sample using bowtie2102 (version 2.3.5.1). The overall alignment rate to the ChHV5
genome was low for both RNA-seq and DNA-seq samples, with most reads
aligning to the green turtle genome (NCBI GenBank Accession numbers:
GCA_000344595.1 and GCA_015237465.1), as expected (Supplementary Data 1).
Transcript abundance for ChHV5 virus-specific transcripts was generated using
htseq-count103 (version 0.6.1p1) with the following parameters: not strand-specific,
feature type ‘gene’, intersection non-empty mode, and a minimum aQual of 0.
Count tables for viral transcripts were merged for all RNA-seq samples and counts
were normalized for gene length and sequencing depth by transcripts per million
(TPM) (Supplementary Data 2). TPMs were generated using the combined host (C.
mydas30) and ChHV5 reads to allow direct comparisons between host and viral
gene expression levels.
Differential expression analysis. Prior to differential expression analysis, a 1 was
added to all gene counts to avoid zero counts in the analysis. The following viral
genes that had the same counts across all samples were removed due to having a
variance of 0 across samples: UL15A, UL15B, UL16, UL20, UL26.5, UL31, UL37,
UL53, HP1/HP1′, HP2/HP2′, HP7, HP8, HP11, HP12, HP14, HP15, HP18, HP21,
HP22, HP23, HP25, HP26, HP27, HP29, HP31, HP38. An external FP tumor
sample, emLFF3H, was also removed from the analysis due to it being an outlier. A
principal component analysis (PCA) plot (see Fig. 4c) was generated using the PtR
script in the Trinity toolkit104. Differential expression analysis was carried out in
the R statistical environment (v 3.4.4) using the quasi-likelihood algorithm within
the software package ‘edgeR’ (v 3.20.9)105–107. Samples were first grouped by
rehabilitation outcome: good outcome (released, n= 46 samples) versus poor
outcome (died in care or humanely euthanized, n= 23 samples). The trimmed
mean of M-values normalization method was then used to calculate effective
library size. To model read counts for each gene, the quasi-likelihood extension for
the negative binomial distribution107 was used. Differential expression analysis was
then conducted in which good outcome was set as the “treatment” and poor
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outcome as the “reference” or “control” group. A false discovery rate (FDR) of 5%
was used as a cut-off to determine significantly differentially expressed viral genes
between rehabilitation outcomes. Results of this analysis are included in Table 1.
Boxplots were generated using BoxPlotR108.
Tissue and eDNA qPCR. qPCR assays were conducted on non-tumor tissue and
FP tissue samples to quantify viral load within a range of tumor types, as well as
water and sand eDNA samples to look at viral shedding dynamics within reha-
bilitation tanks. DNA was extracted from 79 tissue samples from 14 juvenile green
turtles which had stranded in Northern Florida (Supplementary Data 3), 25 tissue
samples from an unhatched green sea turtle and from leeches removed from six
turtles as detailed above. Leeches from the same location were either pooled prior
to extraction (~10 leeches per pool, Fig. 1d), or extracted individually (Fig. 1e,
Supplementary Table 1). DNA was also extracted from 50 tank water samples
(19 samplings with two-three sampling replicates per sampling event) and an
additional 26 tank water samples from one prolonged-duration individual
(13 samplings with 2 sampling replicates per sampling event). DNA was also
extracted from 1 pond water sample (three sampling replicates), on the surface of
the east end of the pond, close to the outflow pipe (Supplementary Fig. 1a). The
fishpond is ~661,000 liters. Environmental DNA was extracted as per the eDNA
sequencing samples above, with 500 ml seawater filtered per tank, except for the
samples in Fig. 4e in which 1-liter seawater per sample was collected. Filtering
(EMD Millipore PES 0.22 μm Sterivex filter) was performed by hand pump, except
for samples depicted in Fig. 4e for which a Geotech Peristaltic Pump was used.
For sand eDNA samples, a 50 ml Falcon conical centrifuge tube was filled with
sand from the base of a plastic holding box used to house an FP-afflicted juvenile
Chelonia mydas (“Archie Carr” 49-2020-Cm) (on two separate occasions,
approximately one month apart). The patient was housed in the box for 30 min,
(dry-docked) during routine rehabilitative treatment at the Whitney Sea Turtle
Hospital. While awaiting examination or receiving treatment, patients are routinely
dry-docked for short periods of time. The 50 ml sand samples were sub-divided
into 2–3 10 ml biological replicates. Each replicate was then washed in 20 ml 1×
IDTE pH 8.0 TE Solution in individual 50 ml Falcon conical centrifuge tubes.
Samples were shaken gently by hand then set on a rocking platform for 1 h at room
temperature, shaking gently by hand every 15 min. Samples were then rested until
sand sunk to the bottom of each tube (~30 s), then the aqueous layer was
immediately pipetted into a 60 ml sterile BD luer lock syringe. Samples were hand
filtered through 0.22 µm Sterivex-GP Pressure Filter Units and capped with B.
Braun luer lock caps. 740 µl Buffer ATL and 60 µl Proteinase K from a Qiagen
DNeasy Blood and Tissue Kit were added to each sample and eDNA was extracted
as described for water eDNA samples (see above).
ChHV5 viral load was quantified using TaqMan Fast Advanced Mastermix
(ThermoFisher, Cat No. 4444557) according to the manufacturer’s protocol by
amplifying the ChHV5 virus-specific DNA polymerase (UL30) gene37
(Supplementary Table 4). A species-specific assay was also developed to target the
16S ribosomal RNA gene (rRNA) for Atlantic populations of C. mydas to serve as
positive controls and to compare the level of viral DNA present against the level of
C. mydas DNA present within each sample (Supplementary Table 4). This sea
turtle species was the primary focus as they are the ones that are most commonly
housed at the Whitney Sea Turtle Hospital and most commonly afflicted by FP. A
LightCycler480 Instrument II (Roche) was used for amplification and cycling
parameters were as follows: 95 °C 10 min, 45 cycles of 95 °C 10 s, 60 °C 20 s, and 72
°C 20 s, or an Applied Biosystems QuantStudio 6 Pro was used for amplification
and cycling parameters were as follows: 50 °C for 2 min, 95 °C for 10 min, 45 cycles
of 95 °C for 15 s and 60 °C for 1 min. All samples were run in triplicate with
negative controls, except sand eDNA samples, fishpond water eDNA samples, leech
samples, and unhatched tissue samples which were run with six technical
replicates. Both absolute quantification and relative quantification methods were
utilized in this study. Standard curves using synthetic fragments of the UL30 gene
and C. mydas 16S rRNA gene (see Supplementary Table 4) were generated to
calculate the amount of DNA of these two genes present within each sample (in pg
of DNA). For relative quantification, the ΔCt method was used, in which a single
sample was set as a reference point to which all other samples were compared.
Tumor burden calculations, statistics, and reproducibility. Tumor burdens were
assessed by total tumor surface area using ImageJ (https://imagej.nih.gov/ij/)1.
ImageJ image analysis was used to make accurate measurements of tumor two-
dimensional surface area, from images taken using an Olympus Tough TG-4 a~30
cm from each lesion, with a 25 cm scale bar for accurate pixel comparison.
For comparison of viral loads (Fig. 5a), data that was normally distributed was
compared using t-tests, for comparison of data that were not normally distributed
(even after log transformation), non-parametric tests (Mann–Whitney U Test)
were performed. Significance was considered to be p values ≤ 0.05. For correlation
of tumor burden with viral shedding, and viral and green turtle eDNA a Pearson
Correlation Coefficient test was used (Fig. 2a,f). The underlying tumor surface area
and ChHV5 concentration data used for the correlation reported in Fig. 2f, is
present in Supplementary Data 4. For comparison of viral loads among different
groups of RNA-seq (Fig. 3a) samples (non-tumor, established FP, regrowth FP,
new growth FP, kidney FP, and lung FP), a Kruskal–Wallis test followed by a
Dunn–Bonferroni post hoc to indicate significant differences among groups was
performed in SPSS (IBM SPSS®).
Histology methodology, embedding, sectioning, and staining. Turtle tissue
samples were surgically removed using a CO2 laser and stored in 4% paraf-
ormaldehyde at 4 °C overnight. Samples were washed twice in 1× PBS for 10 min,
once in Milli-Q H2O for 10 min, twice in 50% ethanol for 15 min, twice in 90%
ethanol for 15 min, and twice in 100% ethanol for 15 min. Samples were then
stored in 100% ethanol at 4 °C for 5 nights. Samples were washed in 100% aniline
for 1 h, 50:50 aniline:methyl salicylate for 1 h, and twice in 100% methyl salicylate
for 1.5 h. Samples were then stored in 50:50 methyl salicylate:paraffin at 60 °C
overnight. Samples were washed twice in 100% paraffin at 60 °C for 3 h. Samples
were then stored in 100% paraffin overnight. Finally, samples were embedded
in 100% paraffin and stored at 4 °C. Paraffin blocks were sectioned into 6 μm
ribbons of six tumor sections each, on charged Fisherbrand Superfrost Plus
microscope slides using an AO Spencer ‘820’ microtome and stored at room
temperature.
For hematoxylin and eosin (H&E) staining, sectioned slides underwent a series
of washes: two 7-min washes in xylene, two 7-min washes in 100% ethanol, two 7-
min washes in 95% ethanol, 2 min in distilled H2O, 2 min in hematoxylin, two 15-s
washes in distilled H2O, 2 min in distilled H2O, 3 min in NH3, 2 min in distilled
H2O, 2 min in 95% ethanol, 1 min in eosin, two 2-min washes in 95% ethanol, two
2-min washes in 100% ethanol, and finally two 2-min washes in xylene. Fisher
Scientific Permount mounting media was added to stained slides, a cover slip was
placed on top, and slides were left to dry overnight before imaging on the Zeiss M2
Axio Imager.
Features of tumors were evaluated by a veterinary pathologist for
comparison with the molecular analysis (Supplementary Table 2). Sections were
examined for intranuclear viral inclusion bodies. The cellularity of the dermal
component of cutaneous tumors and internal tumors was subjectively scored,
by the pathologist, on a scale of 1 (sparsely cellular) to 3 (densely cellular). The
presence of lymphocytic inflammation within the tumors also scored from 0
(absent) to 3 (abundant). The presence of ulceration of the epidermis and
associated heterophilic (granulocytic) inflammation also was noted. These features
were selected as they may represent aspects of tumor development, regression, or
host response relevant to our analysis.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The RNA-Seq and DNA-Seq data including raw reads are deposited in NCBI (https://
www.ncbi.nlm.nih.gov/) under BioProject ID: PRJNA449022.
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